Menumenu
  • slide

    Current practice insights into the use of biologicals

  • slide

    Rapid access to our in-house patient-centric Database Network

  • slide

    An experienced sparring partner for your European healthcare questions

  • slide

    Dedicated to research real-life health care for the benefit of patients

  • icon

    What we do

    As an independent research organisation dedicated to the study of epidemiology, drug utilisation, drug safety, health outcomes, and utilisation of healthcare resources PHARMO assists its clients in their decision-making.

  • icon

    What we have

    PHARMO Database Network: we have rapid access to our rich population-based network of databases. Data are derived from different primary and secondary healthcare settings. For our observational studies disease-specific cohorts are created from the various databases.

Updates

  • News

    PHARMO study published in BMC Urology

    Rates of prostate surgery and acute urinary retention for benign prostatic hyperplasia in men treated with dutasteride or finasteride  The risk of undergoing BPH-related prostate surgery was lower among men using dutasteride compared to men using f...

    Find our latest newsletter online
    In the current issue: biologicals, collaboration with X-IS and annual scientific report

    PHARMO's latest newsletter is published online, click here to read it. Subscribe to our newsletter to receive every new edition in your mailbox and stay up to date of all developments at PHARMO....

    PHARMO study published in Human Psychopharmacology
    Post-authorization safety study comparing quetiapine to risperidone and olanzapine

    Post-authorization safety study comparing quetiapine to risperidone and olanzapine Quetiapine was found to be associated with lower incidence rates of extrapyrimidal symptoms (EPS) and diabetes mellitus compared to olanzapine. Compared to risperidon...

  • Events

    Meet the PHARMO team at ISPOR in Vienna, Austria from October 29th to November 2nd,2016

    The PHARMO team will be present at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 19th Annual European Congress in Vienna, Austria, October 29th - November 2nd, 2016. We would be happy to welcome you at booth #712. If y...

    PHARMO at ICPE Dublin! 

    The PHARMO team had a great time at ICPE Dublin! It was good to meet all the experts in the field, (re)connect with our clients and exchange ideas about the PHARMO Database Network and our expertise in pharmacoepidemiology and drug outcomes researc...

  • Vacancy

    No vacancies

    True to our mission to excel in the interests of improving patient treatment and care, we operate in an entrepreneurial and multidisciplinary environment. The specialists we recruit are from various backgrounds, including: epidemiologists, pharmacist...

Publications

  • Asthma related medication use and exacerbations in children and adolescents with type 1 diabetes

    Read more
  • The effect of aspirin and nonsteroidal anti-inflammatory drug use after diagnosis on survival of oesophageal cancer patients

    Read more
  • Musculoskeletal Hospital Admission and Surgical Procedure Rates among Patients Treated for Rheumatoid Arthritis in the Netherlands 1999-2012

    Read more
  • Prescribing pattern of antipsychotic drugs during the years 1996-2010: a population-based database study in Europe with a focus on torsadogenic drugs

    Read more